Peter Schaeublin Peter Schaeublin

FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer

FundaMental Pharma GmbH (‘FundaMental’ or ‘The Company’), a neuroscience company developing first-in-class small molecule inhibitors for the treatment of a range of neurodegenerative diseases, is pleased to announce the appointment of Dr. Dirk Beher as Chief Executive Officer and Executive Board member.

Read More